drugset / Trial / NCT02549066

Impact of CArdiopulmonary Bypass Flow on Renal Blood Flow, Function and OXygenation

NCT02549066

Completed 18 enrolled Sahlgrenska University Hospital
NaSingle-groupOpen-labelPrevention

Summary

Cardiac surgery with cardiopulmonary bypass (CPB), especially when oxygen delivery is low, is associated with acute kidney injury. Unpublished data shows that renal oxygen delivery is compromised during CPB due to low hematocrit and redistribution of blood flow away from the kidneys. We wish to study if increased CPB flow can improve renal oxygenation. Patients who develop cardiac failure after weaning from CPB will be treated as per our departments routine with the inotropic agent milrinone, and measurements will be made before and after treatment.

Timeline

Start
2016-01
Primary completion
2017-06
Completion
2017-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Milrinone Small molecule 0.5 ug/kg